Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04329533 · ClinicalTrials.gov registry record · NA

Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic

A NA study, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
101
Enrollment target

NCT04329533 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 101 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04329533, a NA study, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target

Study Summary

Due to the COVID-19 global health pandemic, many people are likely experiencing increased stress. Many obstetrics and gynecology patients are additionally experiencing increased stress due to the healthcare changes the COVID-19 pandemic has caused including delayed or canceled elective surgeries, visitor restrictions, and telemedicine visits instead of in person clinic visits. Mindfulness meditation is a self-management strategy that can be utilized by anyone to assist with the management of stress. Mindfulness meditation mobile applications, such as the "Calm" app, can be used to help manage stress, especially during this uncertain time. The investigators propose a prospective randomized controlled trial evaluating perceived stress, anxiety, and sleep disturbance in the investigators outpatient OB/Gyn patients at Banner Women's Institute, with the use of a 30 day trial of the mindfulness meditation app, "Calm." All patients would ultimately receive a 30 day free trial of the mobile meditation app, however the intervention group would receive the 30-day free trial immediately and the control group would receive the 30-day free trial after the study period which is 30 days after enrollment. The investigators additionally want to evaluate the feasibility of using the mobile app, including looking at adherence to use of the app and patient satisfaction with use of the app.

Interventions

  • OTHER "Calm" is a mindfulness meditation mobile app

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2020-04-13
Est. Completion 2020-11-01
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT04329533

The ClinicalTrials.gov registry entry for NCT04329533 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which "Calm" is a mindfulness meditation mobile app is the first listed.

NCT04329533 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04329533 about?

NCT04329533 is a clinical study titled "Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic". Due to the COVID-19 global health pandemic, many people are likely experiencing increased stress. Many obstetrics and gynecology patients are additionally experiencing increased stress due to the healthcare changes the COVID-19 pandemic has caused including delayed or canceled elective surgeries, vi...

What is the current status of trial NCT04329533?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2020-04-13. Estimated completion is 2020-11-01.

What interventions are being tested in trial NCT04329533?

The interventions under investigation include: "Calm" is a mindfulness meditation mobile app (OTHER).

Who is sponsoring clinical trial NCT04329533?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.